臨床試驗管理系統(CTMS)的全球市場預測(到2028年):各零件·各用途·各地區的分析
市場調查報告書
商品編碼
1064170

臨床試驗管理系統(CTMS)的全球市場預測(到2028年):各零件·各用途·各地區的分析

Clinical Trial Management System (CTMS) Market Forecasts to 2028 - Global Analysis By Component (Hardware, Software, Services), Application (Patient Management Solutions, Data Management Solutions) and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球臨床試驗管理系統(CTMS)的市場規模在2021年估算為9億1,875萬美金,2028年前將達到27億827萬美元,在預測期間內預計將以16.7%的年複合成長率成長。

本報告提供全球臨床試驗管理系統(CTMS)市場相關調查分析,提供市場趨勢分析,各市場區隔·各地區的市場資訊,企業簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 用途分析
  • 終端用戶分析
  • 新興市場
  • COVID-19影響

第4章 波特的五力分析

第5章 全球臨床試驗管理系統(CTMS)市場:各零件

  • 硬體設備
  • 軟體
  • 服務

第6章 全球臨床試驗管理系統(CTMS)市場:提供(播送)模式別

  • 雲端基礎(軟體即服務(SaaS))
  • Web為基礎的(隨選)
  • 許可證企業(內部部署)

第7章 全球臨床試驗管理系統(CTMS)市場:各部署

  • 現場
  • 企業規模

第8章 全球臨床試驗管理系統(CTMS)市場:各用途

  • 患者管理解決方案
  • 資料管理解決方案
  • 網站管理解決方案
  • 文件管理解決方案

第9章 全球臨床試驗管理系統(CTMS)市場:各終端用戶

  • 醫療提供者
    • 研究醫院
    • 診所
    • 癌症中心
  • 醫療設備廠商
  • 學術研究中心
  • 開發業務委託機關(CRO)
  • 中小規模的製藥·生物科技企業
  • 大規模的製藥·生物科技企業

第10章 全球臨床試驗管理系統(CTMS)市場:各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東·非洲

第11章 主要發展

  • 契約·夥伴關係·聯盟·合資企業
  • 收購·合併
  • 新產品的銷售
  • 擴張
  • 其他的重要策略

第12章 企業簡介

  • IBM
  • Oracle
  • Bioclinica
  • Veeva Systems
  • Parexel International Corporation
  • PHARMASEAL
  • Advarra Technology Solutions
  • Merge Healthcare
  • Medidata Solutions
  • Bio-Optronics
  • Mednet Solutions
  • DZS Clinical Services(WDB Holdings Co. Ltd)
  • Arisglobal
  • Mastercontrol
  • Datastat
Product Code: SMRC20433

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) Market is accounted for $918.75 million in 2021 and is expected to reach $2,708.27 million by 2028 growing at a CAGR of 16.7% during the forecast period. Clinical Trial Management System (CTMS) is a software system that is customizable and aims at managing the clinical trial data generated in clinical trials conducted by different pharmaceutical companies and clinical research organizations. The management system allows the ease in tracking and monitoring of patients involved in the clinical trials and analyzes huge amounts of data which helps in deciding the safety factors of the products undergoing clinical trials.

Market Dynamics:

Driver:

Availability of advanced CTMS solutions

The life science industry is witnessing a global increase in the number of clinical trials. The growth in the number of clinical trials can be attributed to factors such as the high prevalence of chronic diseases, the expiry of blockbuster drugs, the availability of government funds for clinical trials, and fierce competition in the pharmaceutical industry. In recent years, leading players have launched many CTMS solutions in the market that claim superior performance than their traditional counterparts. These products are cost-effective, easy to use, provide effective patient safety and regulatory compliance, and enhance the financial management capabilities of users. They enable organizations to implement a full-featured CTMS without the complex configuration and heavy capital investment associated with traditional solutions.

Restraint:

Financial constraints

The prevalence of financial constraints for clinical trials is often due to limited private funding, strict regulatory mandates, and financial outlook. This also includes ineffective site selection, poor study design & trial execution, safety issues, and dropouts due to practical or financial issues. Although R&D spending in the life science industry is rising, start-ups and SMEs still face budget constraints, which affect their decision to purchase CTMS solutions. Due to uncertainties and undue delays in product approvals and long gestation periods, private investors usually prefer established firms to invest in rather than start-ups and SMEs.

Opportunity:

Increased innovations by pharma companies

Even though the supply of technology has been increasing and the regulation of innovative methods is easing, pharmaceutical companies have been slow to use emerging technologies due to the uncertainty prevailing around this space and a highly fragmented supply market. Lately, pharma companies have increased expenditure on AI and big data analytics, given their transformative supremacy over the R&D process and cost savings. Fear of rivalry in the market and the need for business transformation and agility are key forces driving huge investments in R&D technologies. Hence, pharma companies must recognize outward innovation through supplier benchmarking in each of these categories and be involved in early engagement through co-development to stay competitive. This would provide ample opportunities for the market.

Threat:

Lack of skilled professionals

The lack of skilled professionals for handling advanced digital solutions in research teams is a major challenge faced by the CTMS market. With severe time constraints and increasing cost cuts, CROs and pharmaceutical companies are reluctant to invest in training their research employees. Hence, a huge gap exists between the available and required skilled manpower in the clinical research industry, restricting the adoption and utilization of complex software solutions in clinical trials. The development of user-friendly software solutions could act as a key growth opportunity for software vendors in this market.

The web-based (on-demand) segment is expected to be the largest during the forecast period

Web-based systems are the most preferred CTM systems. High growth rate is attributed to various advantages associated with web-based solution such as remote access to data and minimal technical issues. Web-based CTMS uses secure enterprise-class data centers to store, update, and back-up on a daily basis. Also, web-based software allows the centralization of data, which facilitates access to data from any location and they help minimize cost associated with system security, backups, upgrades, and uptime consistency.

The software segment is expected to have the highest CAGR during the forecast period

The CTMS software performs various critical functions such as comprehensive management of trial planning, country & site progress and monitoring activities among others. Also, rising number of clinical trials across the globe will increase the acceptance rate, thereby augmenting the industry value over the forecast timeframe. In addition, advancements in CTMS software to ensure effective management of clinical trials data generated by biotech and pharmaceutical companies will accelerate new product launch, thereby supplementing the industry demand.

Region with largest share:

North America is projected to hold the largest market share owing to the strong presence of major pharma and biopharmaceutical companies as well as CROs. Also, extensive drug development activities in the region will further stimulate the usage of clinical trial management system software to manage the data volume. Moreover, the growing clinical research activities in U.S. and rapid shift from manual data elucidation to real-time data analysis during clinical studies will further accelerate the expansion of the CTMS market. Growing concern regarding efficient management of large and confidential data volume will increase the acceptance of CTMS solutions and boost the industry progression in the region.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, faster rate of patient recruitment for clinical trials than mature nations, low operating costs for conducting clinical trials, and the growing number of pharmaceutical companies and CROs in the region.

Key players in the market

Some of the key players profiled in the Clinical Trial Management System (CTMS) Market include IBM, Oracle, Bioclinica, Veeva Systems, Parexel International Corporation, PHARMASEAL, Advarra Technology Solutions, Merge Healthcare, Medidata Solutions, Bio-Optronics, Mednet Solutions, DZS Clinical Services (WDB Holdings Co. Ltd), Arisglobal, Mastercontrol, and Datastat.

Key developments:

In January 2020: Veeva System launched its Vault Payment, a new application for Vault CTMS that help in managing and reimbursement process to clinical research site. This launching strategy enabled company to add value to their existing services portfolio in clinical research and data management, thereby strengthening their business revenue and market presence.

In June 2019: Parexel International Corporation (US) launched an enhanced integrated outsourcing delivery model for functional service provider (FSP) services at the DIA 2019 Global Annual Meeting in San Diego, US.

In May 2019: Bio-optronics launched three products to the CCTrialSuite basket application, namely CCeSource, CCeReg & CCeConsent. These offer users with a range of benefits designed to increase efficiency, cost-effectiveness, and patient-centricity.

In January 2019: PHARMASEAL launched Engility CTMS, the first product to be released from its Engility B2B platform. This strategy enabled company to expand its service offerings and increase its revenue from its sales.

In June 2018: Bioclinica launched eClinical solution namely the SMART Technology Suite. It is available with medical imaging, electronic data capture and interactive response technology combined. SMART allows plug-in functionality with Bioclinica site & patient payments, cardiac safety (ECG and ABPM), and clinical event adjudication, as well as third-party providers.

Components Covered:

  • Hardware
  • Software
  • Services

Delivery Modes Covered:

  • Cloud-Based (Software as a Service (SaaS))
  • Web-Based (On-Demand)
  • Licensed Enterprise (On-Premises)

Deployments Covered:

  • On-Site
  • Enterprise-Wide

Applications Covered:

  • Patient Management Solutions
  • Data Management Solutions
  • Site Management Solutions
  • Document Management Solutions

End Users Covered:

  • Healthcare Providers
  • Medical Device Manufacturers
  • Academic Research Centers
  • Contract Research Organizations (CROs)
  • Small & Mid-Sized Pharma-Biotech Companies
  • Large Pharma-Biotech Companies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Trial Management System (CTMS) Market, By Component

  • 5.1 Introduction
  • 5.2 Hardware
  • 5.3 Software
  • 5.4 Services

6 Global Clinical Trial Management System (CTMS) Market, By Delivery Mode

  • 6.1 Introduction
  • 6.2 Cloud-Based (Software as a Service (SaaS))
  • 6.3 Web-Based (On-Demand)
  • 6.4 Licensed Enterprise (On-Premises)

7 Global Clinical Trial Management System (CTMS) Market, By Deployment

  • 7.1 Introduction
  • 7.2 On-Site
  • 7.3 Enterprise-Wide

8 Global Clinical Trial Management System (CTMS) Market, By Application

  • 8.1 Introduction
  • 8.2 Patient Management Solutions
  • 8.3 Data Management Solutions
  • 8.4 Site Management Solutions
  • 8.5 Document Management Solutions

9 Global Clinical Trial Management System (CTMS) Market, By End User

  • 9.1 Introduction
  • 9.2 Healthcare Providers
    • 9.2.1 Research Hospitals
    • 9.2.2 Clinics
    • 9.2.3 Cancer Centers
  • 9.3 Medical Device Manufacturers
  • 9.4 Academic Research Centers
  • 9.5 Contract Research Organizations (CROs)
  • 9.6 Small & Mid-Sized Pharma-Biotech Companies
  • 9.7 Large Pharma-Biotech Companies

10 Global Clinical Trial Management System (CTMS) Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 IBM
  • 12.2 Oracle
  • 12.3 Bioclinica
  • 12.4 Veeva Systems
  • 12.5 Parexel International Corporation
  • 12.6 PHARMASEAL
  • 12.7 Advarra Technology Solutions
  • 12.8 Merge Healthcare
  • 12.9 Medidata Solutions
  • 12.10 Bio-Optronics
  • 12.11 Mednet Solutions
  • 12.12 DZS Clinical Services (WDB Holdings Co. Ltd)
  • 12.13 Arisglobal
  • 12.14 Mastercontrol
  • 12.15 Datastat

List of Tables

  • Table 1 Global Clinical Trial Management System (CTMS) Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
  • Table 3 Global Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
  • Table 4 Global Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
  • Table 5 Global Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
  • Table 6 Global Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
  • Table 7 Global Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
  • Table 8 Global Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
  • Table 9 Global Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
  • Table 10 Global Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
  • Table 11 Global Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
  • Table 12 Global Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
  • Table 13 Global Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
  • Table 14 Global Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
  • Table 15 Global Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
  • Table 16 Global Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
  • Table 17 Global Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
  • Table 18 Global Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
  • Table 19 Global Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
  • Table 20 Global Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
  • Table 21 Global Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 22 Global Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
  • Table 23 Global Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
  • Table 24 Global Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
  • Table 25 Global Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • Table 26 Global Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 27 Global Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 28 North America Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
  • Table 29 North America Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
  • Table 30 North America Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
  • Table 31 North America Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
  • Table 32 North America Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
  • Table 33 North America Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
  • Table 34 North America Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
  • Table 35 North America Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
  • Table 36 North America Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
  • Table 37 North America Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
  • Table 38 North America Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
  • Table 39 North America Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
  • Table 40 North America Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
  • Table 41 North America Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
  • Table 42 North America Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
  • Table 43 North America Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
  • Table 44 North America Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
  • Table 45 North America Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
  • Table 46 North America Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
  • Table 47 North America Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
  • Table 48 North America Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 49 North America Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
  • Table 50 North America Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
  • Table 51 North America Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
  • Table 52 North America Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • Table 53 North America Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 54 North America Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 55 Europe Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
  • Table 56 Europe Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
  • Table 57 Europe Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
  • Table 58 Europe Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
  • Table 59 Europe Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
  • Table 60 Europe Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
  • Table 61 Europe Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
  • Table 62 Europe Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
  • Table 63 Europe Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
  • Table 64 Europe Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
  • Table 65 Europe Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
  • Table 66 Europe Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
  • Table 67 Europe Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
  • Table 68 Europe Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
  • Table 69 Europe Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
  • Table 70 Europe Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
  • Table 71 Europe Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
  • Table 72 Europe Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
  • Table 73 Europe Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
  • Table 74 Europe Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
  • Table 75 Europe Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 76 Europe Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
  • Table 77 Europe Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
  • Table 78 Europe Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
  • Table 79 Europe Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • Table 80 Europe Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 81 Europe Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 82 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
  • Table 83 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
  • Table 84 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
  • Table 85 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
  • Table 86 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
  • Table 87 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
  • Table 88 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
  • Table 89 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
  • Table 90 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
  • Table 91 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
  • Table 92 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
  • Table 93 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
  • Table 94 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
  • Table 95 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
  • Table 96 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
  • Table 97 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
  • Table 98 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
  • Table 99 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
  • Table 100 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
  • Table 101 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
  • Table 102 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 103 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
  • Table 104 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
  • Table 105 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
  • Table 106 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • Table 107 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 108 Asia Pacific Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 109 South America Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
  • Table 110 South America Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
  • Table 111 South America Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
  • Table 112 South America Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
  • Table 113 South America Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
  • Table 114 South America Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
  • Table 115 South America Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
  • Table 116 South America Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
  • Table 117 South America Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
  • Table 118 South America Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
  • Table 119 South America Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
  • Table 120 South America Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
  • Table 121 South America Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
  • Table 122 South America Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
  • Table 123 South America Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
  • Table 124 South America Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
  • Table 125 South America Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
  • Table 126 South America Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
  • Table 127 South America Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
  • Table 128 South America Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
  • Table 129 South America Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 130 South America Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
  • Table 131 South America Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
  • Table 132 South America Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
  • Table 133 South America Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • Table 134 South America Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 135 South America Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 136 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Country (2020-2028) ($MN)
  • Table 137 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Component (2020-2028) ($MN)
  • Table 138 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Hardware (2020-2028) ($MN)
  • Table 139 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Software (2020-2028) ($MN)
  • Table 140 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Services (2020-2028) ($MN)
  • Table 141 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Delivery Mode (2020-2028) ($MN)
  • Table 142 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Cloud-Based (Software as a Service (SaaS)) (2020-2028) ($MN)
  • Table 143 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Web-Based (On-Demand) (2020-2028) ($MN)
  • Table 144 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Licensed Enterprise (On-Premises) (2020-2028) ($MN)
  • Table 145 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Deployment (2020-2028) ($MN)
  • Table 146 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By On-Site (2020-2028) ($MN)
  • Table 147 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Enterprise-Wide (2020-2028) ($MN)
  • Table 148 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Application (2020-2028) ($MN)
  • Table 149 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Patient Management Solutions (2020-2028) ($MN)
  • Table 150 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Data Management Solutions (2020-2028) ($MN)
  • Table 151 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Site Management Solutions (2020-2028) ($MN)
  • Table 152 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Document Management Solutions (2020-2028) ($MN)
  • Table 153 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By End User (2020-2028) ($MN)
  • Table 154 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Healthcare Providers (2020-2028) ($MN)
  • Table 155 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Research Hospitals (2020-2028) ($MN)
  • Table 156 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 157 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Cancer Centers (2020-2028) ($MN)
  • Table 158 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Medical Device Manufacturers (2020-2028) ($MN)
  • Table 159 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Academic Research Centers (2020-2028) ($MN)
  • Table 160 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • Table 161 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Small & Mid-Sized Pharma-Biotech Companies (2020-2028) ($MN)
  • Table 162 Middle East & Africa Clinical Trial Management System (CTMS) Market Outlook, By Large Pharma-Biotech Companies (2020-2028) ($MN)